Old Web
English
Sign In
Acemap
>
authorDetail
>
Maemondo Makoto
Maemondo Makoto
thesaurus
World Wide Web
Engineering
egfr mutation
Internal medicine
5
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase III study comparing bevacizumab plus erlotinib (BE) to erlotinib(E) for NSCLC with EGFR mutations (NEJ026)
2018
Fukuhara Tatsuro
Furuya Naoki
Saito Haruhiro
Sugawara Shunichi
Iwasawa Shunichiro
Tsunezuka Yoshio
Yamaguchi Ou
Okada Morihito
Yoshimori Kozo
Nakachi Ichiro
Hagiwara Koichi
Nukiwa Toshihiro
Morita Satoshi
Kobayashi Kunihiko
Maemondo Makoto
Show All
Source
Cite
Save
Citations (0)
以前に処置された野生型EGFR進行型非小細胞肺癌患者に対するドセタキセル+個別化ペプチドワクチン接種対ドセタキセル+プラセボの無作為化第II相研究
2016
Takayama Koichi
Sugawara Shunichi
Saijo Yasuo
Maemondo Makoto
Sato Atsushi
Takamori Shinzo
Harada Taishi
Sasada Tetsuro
Kakuma Tatsuyuki
Kishimoto Junji
Yamada Akira
Noguchi Masanori
Itoh Kyogo
Nakanishi Yoichi
Show All
Source
Cite
Save
Citations (0)
非小細胞肺癌に対する3・4次治療としての塩酸アムルビシン(AMR)療法の第II相試験(HOT0901)
2013
Watanabe Kana
Harada Toshiyuki
Takamura Kei
Oizumi Satoshi
Sugawara Toshikazu
Maemondo Makoto
Fujita Yuka
Kinoshita Ichiro
Inoue Akira
Akita Hirotoshi
Isobe Hiroshi
Nishimura Masaharu
Show All
Source
Cite
Save
Citations (0)
切除不能進行胸腺腫・胸腺癌に対するアムルビシン・カルボプラチン併用療法の第2相試験(NJLCG0803)
2013
Kozuki Toshiyuki
Inoue Akira
Kawashima Yosuke
Sugawara Toshikazu
Sakakibara Tomohiro
Harada Masao
Kobayashi Kunihiko
Hisayama Shoichi
Maemondo Makoto
Asahina Hajime
Hisamoto Akiko
Nakagawa Hiroshi
Nukiwa Toshihiro
Show All
Source
Cite
Save
Citations (0)
進行肺非小細胞癌(NSCLC)の高齢患者(pts)における毎週パクリタキセル併用カルボプラチン(CwP)とドセタキセル単独(D)のランダム化第二相試験:NJLCG 0801
2012
Inoue Akira
Maemondo Makoto
Sugawara Shunichi
Harada Toshiyuki
Minegishi Yuji
Usui Kazuhiro
Ando Masahiro
Morikawa Naoto
Mori Yoshiaki
Ishimoto Osamu
Matsubara Nobumichi
Sakakibara Tomohiro
Watanabe Kana
Gemma Akihiko
Nukiwa Toshihiro
Show All
Source
Cite
Save
Citations (0)
1